Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DALLAS, TX and NEW YORK, NY--(Marketwired - May 27, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and...
-
NEW YORK, NY--(Marketwired - May 26, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based...
-
PlasmaTech Biopharmaceuticals Announces Orphan Drug and Rare Pediatric Disease Designations From FDA
NEW YORK, NY--(Marketwired - May 20, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on gene therapy and plasma-based products for severe and life-...
-
NEW YORK, NY--(Marketwired - May 18, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on gene therapy and cell therapy products for severe and life-...
-
NEW YORK, NY--(Marketwired - May 15, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on gene therapy and cell therapy products for severe and life-...
-
NEW ORLEANS, LA--(Marketwired - May 14, 2015) - Preclinical Studies Support Strong Safety Profile and Investigational New Drug (Ind) Application Filing for Treating Sanfilippo Syndrome...
-
DALLAS, TX and NEW YORK, NY--(Marketwired - May 12, 2015) - PlasmaTech Biopharmaceuticals, Inc. ("PlasmaTech" or the "Company") (NASDAQ: PTBI), a biopharmaceutical company focused on advancing cell...
-
DALLAS, TX and NEW YORK, NY--(Marketwired - May 11, 2015) - PlasmaTech Biopharmaceuticals, Inc. ("PlasmaTech" or the "Company"), (NASDAQ: PTBI), a biopharmaceutical company focused on advancing cell...
-
DALLAS, TX and NEW YORK, NY--(Marketwired - May 06, 2015) - PlasmaTech Biopharmaceuticals, Inc. ("PlasmaTech" or the "Company"), (NASDAQ: PTBI), announced today that it has entered into a definitive...
-
DALLAS, TX and CLEVELAND, OH and NEW YORK, NY--(Marketwired - May 06, 2015) - Company is well positioned to execute on its strategy to become a leader in cell therapy and gene therapy for rare...